Differential inhibition of inflammatory cytokine release from cultured alveolar macrophages from smokers and nonsmokers by No2

Human and Experimental Toxicology

Volumn 16, Issue 10, 1997, Pages 577-588

  Dandrea, Tiziana ^a   Tu, Ba ^a   Blomberg, Anders ^c   Sandström, Thomas ^c   Sköld, Magnus ^b   Eklund, Anders ^b   Cotgreave, Ian ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alveolar macrophage; Cytokine release; Gene expression; Nitrogen dioxide; Smoking

Indexed keywords

CIGARETTE SMOKE; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; NITROGEN DIOXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING;

EID: 0030830509     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719701601005     Document Type: Article

References (41)

1. Sandström T, Andersson M-C, Kolmodin-Hedman B, Stjernberg N, Angström T. Bronchoalveolar mastocytosis and lymphocytosis after nitrogen dioxide exposure in man: a time kinetic study. Eur. Respir. J. 1990; 3: 138-143.
2. Helliday R, Sandsröm T, Stjernberg N. Difference in bronchoalveolar cell response to nitrogen dioxide exposure between smokers and non-smokers. Eur. Respir. J. 1994; 7: 1213-1220.
3. Sandström T. Respiratory effects of air pollutants. Experimental studies in humans. Eur. Respir. J. 1995; 8: 976-995.
4. Nathan CF. Secretory products of macrophages. J. Clin. Invest. 1987; 79: 319-326.
5. Pérez-Arellano JL, Alcázar-Montero MC, Jiménez-López A. Alveolar macrophage: Origin, kinetics and relationship with cells of the alveolo-interstitial region. Allergol. Immunopathol. 1990; 18: 175-183.
6. Crystal RG. Alveolar macrophages. In: The Lung: Scientific Foundations. GR Crystal, JB West ef al., (ed) Raven Press, Ltd: New York. pp. 527-538, 1991.
7. Frampton MW et al. Nitrogen dioxide exposure in vivo and human alveolar macrophage inactivation of influenza virus in vitro. Environ. Res. 1989; 48: 179-192.
8. McCrea KA et al. Altered cytokine regulation in the lung of cigarette smokers. Am. J. Respir. Crit. Care Med. 1994; 150: 696-703.
9. Pratt SA, Smith MH, Ladman AJ, Finley TN. The ultrastructure of alveolar macrophages from human cigarette smokers and non-smokers. Lab. Invest. 1971; 24: 331-338.
10. Hoidal JR et al. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am. Rev. Respir. Dis. 1981; 123: 85-89.
11. Fels ADS, Cohn ZA. The alveolar macrophage. J. Appl. Physiol. 1986; 60: 353-369.
12. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 1990; 141: 471-501.
13. Martinet Y, Yamauchi K, Crystal RG. Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phabocytes. Am. Rev. Respir. Dis. 1988; 138: 659-665.
14. Koretzky GA et al. Spontaneous production of interleukin-1 by human alveolar macrophages. Clin. Immunol. Immunopathol. 1983; 29: 443-450.
15. Bevilacqua MP et al. Interleukin-1 acts of cultured human vascular endothelium to increase the adherence of polymorphonuclear leukocytes, monocytes and related cell lines. J. Clin. Invest. 1985; 76: 2003-2011.
16. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 1985; 82: 8667-8671.
17. Stricter RM et al. Human alveolar macrophage gene expresion of interleukin-8 by tumor necrosis factor-α, lipopolysaccharide, and interleukin-1β. Am. J. Respir. Cell Mol. Biol. 1990; 2: 321-326.
18. Standiford TJ et al. Gene expression of macrophage inflammatory protein-1a from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am. J. Respir. Cell Mol. Biol. 1993; 9: 192-198.
19. Tu B, Wallin A, Moldéus P, Cotgreave I. Direct exposure to nitrogen dioxide fails to induce the expression of some inflammatory cytokines in an IC-21 murine macrophage cell model. Toxicology 1995; 105: 159-164.
20. Thomassen MJ et al. Human alveolar macrophage function: differences between smokers and nonsmokers. J. Leukocyte Biol. 1988; 44: 313-318.
21. 4 but not other chemotactic factors. Eur. J. Respir. Dis. 1987; 71: 263-272.
22. Brown GP, Iwamoto GK, Monick MM, Hunninghake GW. Cigarette smoking decrease interleukin-1 release by human alveolar macrophages. Am. J. Physiol. 1989; 256: C260-C264.
23. Yamaguchi E et al. Interleukin-1 production by alveolar macrophages is decreased in smokers. Am. Rev. Respir. Dis. 1989; 140: 397-402.
24. Sauty A, Mauel J, Philippeaux M-M, Leuenberger P. Cytostatic activity of alveolar macrophages from smokers and non-smokers: role of interleukin-1β, interleukin-6, and tumor necrosis factor-α. Am. J. Respir. Cell. Mol. Biol. 1994; 11: 631-637.
25. Soliman DM, Twigg III HL. Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am. J. Physiol. 1992; 263 (Lung Cell. Mol. Physiol. 7): L471-L478.
26. Higashimoto Y et al. Inhibition of mouse alveolar macrophage production of tumor necrosis factor alpha by acute in vivo and in vitro exposure to tobacco smoke. Respiration 1992; 59: 77-80.
27. Nagai S et al. Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects. Chest 1988; 94: 694-700.
28. Renoux M, Lemarié E, Renoux G. Interleukin-1 secretion by lipopolysaccharide-stimulated alveolar macrophages. Respiration 1989; 55: 158-168.
29. Mayorga MA. Overview of nitrogen dioxide effects on the lung with emphasis on military relevance. Toxicology 1994; 89: 175-192.
30. Sköld CM, Hed J and Eklund A. Smoking cessation rapidly reduces cell recovery in bronchoalveolar lavage fluid, while alveolar macrophage fluorescence remains high. Chest 1992; 101: 989-959.
31. 2 gas to cultured human and murine cells in an inverted monolayer exposure system. Toxicology 1995; 96: 7-18.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochem. 1987; 162: 56-159.
33. 450 in human fetal tissues as determined by competitive polymerase chain reaction amplification. J. Clin. Endocrinol. Metab., 1992; 74: 879-883.
34. Siebert PD, Larrick JW. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. BioTechniques, 1993; 14: 244-249.
35. Kayama F, Yoshida T, Elwell MR, Luster MI. Role of tumor necrosis factor-α in cadmium-induced hepatotoxicity. Toxicol. Appl. Pharmacol., 1995; 131: 224-234.
36. Standiford TJ et al. Interleukin-8 gene expression from human alveolar macrophages: the role of adherence. Am. J. Respir. Cell Mol. Biol. 1991; 5: 579-585.
37. Strieter RM et al. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-α, lipopolysaccharide, and interleukin-1β. Am. J. Respir. Cell Mol. Biol. 1990; 2: 321-326.
38. Standiford TJ et al. Gene expression of macrophage inflammatory protein-1a from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am. J. Respir. Cell Mol. Biol. 1993; 9: 192-198.
39. Thomassen MJ et al. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am. J. Respir. Cell Mol. Biol. 1994; 10: 399-404.
40. Scheule PK, Perkins RC, Hamilton R, Holian A. 1992. Bleomycin stimulation of cytokine secretion by the human alveolar macrophages. Am. J. Physiol. 1992; 262 (Lung Cell Mol. Physiol. 6): L386-L391.
41. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax. 1987; 42: 241-249.